Molecular Therapy - Methods & Clinical Development

Slides:



Advertisements
Similar presentations
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
Advertisements

Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1
Molecular Therapy - Methods & Clinical Development
Stephen Lory, PhD, Jeffrey K. Ichikawa, PhD  CHEST 
Volume 24, Issue 3, Pages (March 2016)
Genotyping of Chimerical BCR-ABL1 RNA in Chronic Myeloid Leukemia by Integrated DNA Chip  Jong-Hun Kang, Hyun-Gyung Goh, Sang-Ho Chae, Sung-Yong Kim,
A Rapid Polymerase Chain Reaction-Based Screening Method for Identification of All Expanded Alleles of the Fragile X (FMR1) Gene in Newborn and High-Risk.
Molecular Therapy - Oncolytics
Volume 8, Issue 1, Pages (January 1998)
Comparison of BIOMED-2 Versus Laboratory-Developed Polymerase Chain Reaction Assays for Detecting T-Cell Receptor-γ Gene Rearrangements  Keyur P. Patel,
Jonathan A. Schumacher, Stephen D. Jenson, Kojo S. J
Noninvasive Molecular Monitoring in Multiple Myeloma Patients Using Cell-Free Tumor DNA  Giulia Biancon, Silvia Gimondi, Antonio Vendramin, Cristiana.
The homeodomain protein Cdx2 regulates lactase gene promoter activity during enterocyte differentiation  Rixun Fang, Nilda A. Santiago, Lynne C. Olds,
Multiplex Ligation-Dependent Probe Amplification
by Guang Yang, Shu-Ching Huang, Jane Y. Wu, and Edward J. Benz
Sequencing of t(2;7) Translocations Reveals a Consistent Breakpoint Linking CDK6 to the IGK Locus in Indolent B-Cell Neoplasia  Edward P.K. Parker, Reiner.
CpG Methylation of a Plasmid Vector Results in Extended Transgene Product Expression by Circumventing Induction of Immune Responses  A. Reyes-Sandoval,
Molecular Therapy - Methods & Clinical Development
Claire Soudais, Sylvie Boutin, Eric J. Kremer  Molecular Therapy 
Molecular Therapy - Nucleic Acids
Bulge- and Basal Layer-Specific Expression of Fibroblast Growth Factor-13 (FHF-2) in Mouse Skin  Mitsuko Kawano, Satoshi Suzuki, Masashi Suzuki, Junko.
Biological Insights into TCRγδ+ and TCRαβ+ Intraepithelial Lymphocytes Provided by Serial Analysis of Gene Expression (SAGE)  John Shires, Efstathios.
Complete Cure of Persistent Virus Infections by Antiviral siRNAs
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
ATLAS: A System to Selectively Identify Human-Specific L1 Insertions
Molecular Characterization, Reactivation, and Depletion of Latent HIV
Development of a Novel One-Tube Isothermal Reverse Transcription Thermophilic Helicase-Dependent Amplification Platform for Rapid RNA Detection  James.
Molecular Therapy - Methods & Clinical Development
Barbara R. Migeon, Catherine H. Lee, Ashis K
Molecular Therapy - Methods & Clinical Development
Volume 64, Issue 4, Pages (October 2003)
Fyn Can Partially Substitute for Lck in T Lymphocyte Development
Haiyan Dong, Ji Ma, Jie Wang, Zai-Sheng Wu, Patrick J Sinko, Lee Jia 
Ras Induces Mediator Complex Exchange on C/EBPβ
Novel Fluorescent Ligase Detection Reaction and Flow Cytometric Analysis of SYT-SSX Fusions in Synovial Sarcoma  Robyn Gaffney, Artemis Chakerian, John.
Rapid identification of efficient target cleavage sites using a hammerhead ribozyme library in an iterative manner  Wei-Hua Pan, Ping Xin, Vuong Bui,
G. Charles Ostermeier, Ph. D. , Robert J. Goodrich, B. S. , Michael P
Molecular Therapy - Nucleic Acids
Jun Zhan, Irudayam Maria Johnson, Matthew Wielgosz, Arthur W Nienhuis 
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Helper virus-mediated downregulation of transgene expression permits production of recalcitrant helper-dependent adenoviral vector  Donna J Palmer, Nathan.
Ye Bang-Ce, Chu Xiaohe, Fan Ye, Li Songyang, Yin Bincheng, Zuo Peng 
Volume 43, Issue 5, Pages (November 2015)
Volume 33, Issue 3, Pages (September 2010)
GFP to BFP Conversion: A Versatile Assay for the Quantification of CRISPR/Cas9- mediated Genome Editing  Astrid Glaser, Bradley McColl, Jim Vadolas  Molecular.
Richard A Voit, Moira A McMahon, Sara L Sawyer, Matthew H Porteus 
Frpo: A Novel Single-Stranded DNA Promoter for Transcription and for Primer RNA Synthesis of DNA Replication  Hisao Masai, Ken-ichi Arai  Cell  Volume.
Olivier Humbert, Nancy Maizels  Molecular Therapy - Nucleic Acids 
Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells
Regulation of the Expression of Peptidylarginine Deiminase Type II Gene (PADI2) in Human Keratinocytes Involves Sp1 and Sp3 Transcription Factors  Sijun.
PPARδ Is a Type 1 IFN Target Gene and Inhibits Apoptosis in T Cells
Volume 24, Issue 1, Pages (January 2006)
Volume 25, Issue 2, Pages (February 2017)
Md Nasimuzzaman, Danielle Lynn, Johannes CM van der Loo, Punam Malik 
Volume 16, Issue 1, Pages (January 2006)
Molecular Therapy - Methods & Clinical Development
Template Switching by RNA Polymerase II In Vivo
Rodney P. DeKoter, Hyun-Jun Lee, Harinder Singh  Immunity 
Thomas M. Schmitt, Juan Carlos Zúñiga-Pflücker  Immunity 
Molecular Therapy - Nucleic Acids
David A. Norris, Brian L. Kotzin  Journal of Investigative Dermatology 
Molecular Therapy - Oncolytics
Molecular Therapy - Nucleic Acids
Single-Shot, Multicycle Suicide Gene Therapy by Replication-Competent Retrovirus Vectors Achieves Long-Term Survival Benefit in Experimental Glioma  Chien-Kuo.
Molecular Therapy - Methods & Clinical Development
Volume 9, Issue 5, Pages (May 2004)
Figure 1 The workflow of CAR development from a hybridoma
Volume 33, Issue 1, Pages (July 2010)
High-level production of replication-defective human immunodeficiency type 1 virus vector particles using helper-dependent adenovirus vectors  Yani Hu,
Exon Skipping in IVD RNA Processing in Isovaleric Acidemia Caused by Point Mutations in the Coding Region of the IVD Gene  Jerry Vockley, Peter K. Rogan,
Presentation transcript:

Molecular Therapy - Methods & Clinical Development Rapid cloning, expression, and functional characterization of paired αβ and γδ T-cell receptor chains from single-cell analysis  Xi-zhi J Guo, Pradyot Dash, Matthew Calverley, Suzanne Tomchuck, Mari H Dallas, Paul G Thomas  Molecular Therapy - Methods & Clinical Development  Volume 3, (January 2016) DOI: 10.1038/mtm.2015.54 Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Unbiased single-cell amplification of paired T-cell receptor (TCR) CDR3 regions. (a) Overview of the multiplex polymerase chain reaction (PCR) protocol to amplify and sequence paired TCR CDR3 α/γ and CDR3 β/δ. After sorting single human αβ or γδ T cells into a 96-well plate, reverse transcription is performed to obtain single-cell cDNA. Taking human γδ T cells as an example, a first round of PCR is performed by using an external primer mixture of nine TRGV and eight TRDV sense and single TRGC and TRDC antisense primers following reverse transcription (RT) PCR. The first-round PCR products are subjected to two separate second-round PCRs using a corresponding internal primers mix (nine sense TRGV, single antisense TRGC, and eight sense TRDV, single antisense TRDC, respectively). The timeline of this process is shown on the left. (b) An agarose gel electrophoresis image of TCR segments containing CDR3γ and CDR3δ is shown. Paired CDR3γ and CDR3δ products from the same cell were loaded in adjacent lanes. Negative control PCR reactions are shown in the boxed region and in the ladder lane, a 500 bp label is shown. (c) Paired TRGV/TRDV usage is determined by multiplex PCR and sequencing (n=14 human apheresis rings). The percentage of different TRGV/TRDV usage in each sample was assessed (mean ± standard error of the mean). Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2015.54) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 Rapid cloning and expression of human TCRαβ or TCRγδ in a retroviral vector. (a) A schematic diagram of T-cell receptor (TCR) cloning using gBlock synthesized DNA fragments and a linearized retroviral vector (pMICherry) is shown. Family-specific TRGV and TRDV full-length TCR chains were synthesized with a 15–20 bp overlap sequence (purple) in the 2A region (pink). Together with a linearized pMICherry expression vector, a three-way ligation is performed by using Gibson Assembly Cloning. The timeline of this process is presented on the left. (b) Expression of TCR constructs in the Jurkat 76 TCRα–β– cell line. The vectors with human TRGV9/TRDV2 TCR genes (top panel) and human influenza-specific TCRαβ genes (bottom panel) were cotransfected with the human CD3 construct into the Jurkat 76 TCRα–β– cell line. The flow cytometry results of transfected cells are shown Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2015.54) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 Nur77-GFP Jurkat 76 TCRα–β– cells can report the T-cell receptor (TCR) signaling activation. (a) Following cotransfection of a murine KbPB1703-specific TCR αβ derived from influenza-infected mice and a mouse CD3 construct, the KbPB1703+TCRαβ+ NJ76 cells (PB1-NJ76) were stimulated either with influenza PB1703 peptide alone or PB1703 peptide-pulsed splenotytes for 4 hours. Anti-mouse CD3/α-human CD28 stimulation was also done as a positive control. The GFP expression was assessed by flow cytometry. (b) The quantification of GFP expression in PB1-NJ76 cells is shown. Statistical differences were determined by one-way analysis of variance (ANOVA). (c) The transfected human TRGV9/TRDV2-NJ76 cells were pulsed with zoledronic acid (50 μg/ml) for 3 hours at 37 °C, and washed and incubated at 37 °C for 12 hours. The GFP expression of stimulated NJ76 cells (gray line), nonstimulated TRGV9/TRDV2-NJ76 (black line) and stimulated TRGV9/TRDV2-NJ76 cells (red line) is shown (top panel). Fold change of GFP expression in stimulated TRGV9/TRDV2-NJ76 cells (red line) compared to nonstimulated TRGV9/TRDV2-NJ76 (black line) is shown as a time course (bottom panel). Statistical differences were determined by two-way ANOVA; P < 0.05 was considered statistically significant. Data are mean ± standard error of the mean of two independent experiments. **P < 0.01, ***P < 0.001, ****P < 0.0001. n.s., nonsignificant. Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2015.54) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 4 Schematic strategy of CDR3 substitution by overlap extension polymerase chain reaction (PCR). Based on the library of TCRαβ and TCRγδ established by the described cloning platform, the strategy for CDR3 substitution using multiplex single cell PCR products and linker DNA is shown. After the sequence analysis of single-cell PCR (shown in Figure 1a), the target pairs of T-cell receptors (TCRs) are chosen from the respective second round paired PCR plates, which include TCRα/γm and TCRβ/δn (m represents a particular TRAV or TRGV subfamily; n represents a particular TRBV or TRDV subfamily). Beforehand, we generated a library of linker DNA by gBlock synthesis (Integrated DNA Technologies) (Figure 5). The linker DNA consists of TRAC/TRGC-2A-TRBVn/TRDVn (n represents the TRB/DV subfamily) sequence. Using the single cell PCR products of α/γ and β/δ chains of the desired clonotypes and the relevant linker gBlock DNA, we carried out an overlap PCR with TRAm/GVm internal sense primer and TRB/DC internal antisense primer. The PCR products were visualized on an agarose gel, and subsequently purified to use as “mega-primer” for cloning into the existing construct from our TCR cloning library (pMIC-TCRα/γm-TCR β/δn) with the same TRGV and TRDV family usage but different CDR3s by overlap extension PCR. The timeline of the whole process is on the left. Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2015.54) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 5 Human TCRγδ linker DNA library. Yellow color indicates TC sequence; pink color indicates 2A sequence; and gray color indicates TRDVx sequence. Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2015.54) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions